| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2448 | 2020 |
| Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline SR Bornstein, B Allolio, W Arlt, A Barthel, A Don-Wauchope, GD Hammer, ... The Journal of Clinical Endocrinology & Metabolism 101 (2), 364-389, 2016 | 1542 | 2016 |
| Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma D Astuti, F Latif, A Dallol, PLM Dahia, F Douglas, E George, F Sköldberg, ... The American Journal of Human Genetics 69 (1), 49-54, 2001 | 1268 | 2001 |
| Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines K Kisand, AS Bøe Wolff, KT Podkrajšek, L Tserel, M Link, KV Kisand, ... Journal of Experimental Medicine 207 (2), 299-308, 2010 | 729 | 2010 |
| Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1 A Meager, K Visvalingam, P Peterson, K Möll, A Murumägi, K Krohn, ... PLoS medicine 3 (7), e289, 2006 | 478 | 2006 |
| Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry MM Erichsen, K Løvås, B Skinningsrud, AB Wolff, DE Undlien, ... The Journal of Clinical Endocrinology & Metabolism 94 (12), 4882-4890, 2009 | 461 | 2009 |
| Consensus statement on the diagnosis, treatment and follow‐up of patients with primary adrenal insufficiency ES Husebye, B Allolio, W Arlt, K Badenhoop, S Bensing, C Betterle, ... Journal of internal medicine 275 (2), 104-115, 2014 | 432 | 2014 |
| Autoimmune polyendocrine syndromes ES Husebye, MS Anderson, O Kämpe New England Journal of Medicine 378 (12), 1132-1141, 2018 | 426 | 2018 |
| Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I ES Husebye, J Perheentupa, R Rautemaa, O Kämpe Journal of internal medicine 265 (5), 514-529, 2009 | 419 | 2009 |
| Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen M Alimohammadi, P Björklund, Å Hallgren, N Pöntynen, G Szinnai, ... New England Journal of Medicine 358 (10), 1018-1028, 2008 | 305 | 2008 |
| High prevalence and increasing incidence of Addison's disease in western Norway K Løvås, ES Husebye Clinical endocrinology 56 (6), 787-791, 2002 | 294 | 2002 |
| Subjective health status in Norwegian patients with Addison’s disease K Løvås, JH Loge, ES Husebye Clinical endocrinology 56 (5), 581-588, 2002 | 289 | 2002 |
| Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I A Söderbergh, AG Myhre, O Ekwall, G Gebre-Medhin, H Hedstrand, ... The Journal of Clinical Endocrinology & Metabolism 89 (2), 557-562, 2004 | 280 | 2004 |
| Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death MM Erichsen, K Løvås, KJ Fougner, J Svartberg, ER Hauge, J Bollerslev, ... European journal of endocrinology 160 (2), 233-237, 2009 | 279 | 2009 |
| Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene ASB Wolff, MM Erichsen, A Meager, NF Magitta, AG Myhre, J Bollerslev, ... The Journal of Clinical Endocrinology & Metabolism 92 (2), 595-603, 2007 | 269 | 2007 |
| AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies S Meyer, M Woodward, C Hertel, P Vlaicu, Y Haque, J Kärner, A Macagno, ... Cell 166 (3), 582-595, 2016 | 264 | 2016 |
| Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases BE Oftedal, A Hellesen, MM Erichsen, E Bratland, A Vardi, J Perheentupa, ... Immunity 42 (6), 1185-1196, 2015 | 258 | 2015 |
| Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I A Meloni, M Furcas, F Cetani, C Marcocci, A Falorni, R Perniola, M Pura, ... The Journal of Clinical Endocrinology & Metabolism 93 (11), 4389-4397, 2008 | 235 | 2008 |
| AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype M Halonen, P Eskelin, AG Myhre, J Perheentupa, ES Husebye, ... The Journal of Clinical Endocrinology & Metabolism 87 (6), 2568-2574, 2002 | 235 | 2002 |
| A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes NF Magitta, AS Bøe Wolff, S Johansson, B Skinningsrud, BA Lie, KM Myhr, ... Genes & Immunity 10 (2), 120-124, 2009 | 220 | 2009 |
